FEB 06, 2014 12:00 PM PST

Molecular Diagnostic Tests To Advance Health Monitoring of Laboratory Zebrafish

C.E. Credits: CE
Speaker
  • Head of Aquatic Diagnostics, IDEXX Bioresearch. USA
    Biography
      Marcus is the Head of Aquatic Diagnostics at IDEXX BioResearch. He earned his DVM and MBA at Texas A&M University and received residency training in laboratory animal medicine from the Comparative Medicine Program at the University of Missouri. His professional interests include the characterization and pathobiology of naturally-occurring infectious diseases in zebrafish and other aquatic laboratory species and the development of diagnostic tests which facilitate effective health monitoring.

    Abstract

    The zebrafish, Danio rerio, is an ideal model organism to address a broad array of biomedical questions, and is now widely employed to answer questions about aging, behavior, cancer, growth, immunity, infection, metabolism and toxicology, using adult fish as well as embryos. However, the rapid expansion of the zebrafish as a model organism has outpaced the design and implementation of sentinel health monitoring programs in zebrafish colonies. Unlike rodent facilities, relatively few zebrafish facilities have health monitoring programs in place. Several studies now document the confounding effects of subclinical disease in zebrafish, and extensive evidence from other animal models demonstrates that both clinical and subclinical naturally-occurring infections can result in invalid or confounded experimental results. Improvement in the health monitoring of zebrafish colonies is therefore an important objective in zebrafish facility management. Health monitoring for zebrafish colonies historically relied on traditional methods, such as histopathology and wet mounts. Recently, however, molecular diagnostic assays have been developed for multiple pathogens, including five parasites, Pseudoloma neurophilia, Pseudocapillaria tomentosa, Piscinoodinium pillulare, Pleistophora hyphessobryconis, and Ichthyophthirius multifiliis, four bacterial pathogens, Edwardsiella ictaluri, Mycobacterium chelonae, Mycobacterium haemophilum, and Mycobacterium marinum, and one emerging virus with a broad host range, Infectious spleen and kidney necrosis virus (ISKNV). Clinical validation studies comparing the molecular assay results with traditional diagnostic methods demonstrated that molecular diagnostic assays were more sensitive than traditional methods. The availability of sensitive molecular diagnostic assays enables laboratory animal veterinarians, facility managers, and investigators to design health monitoring programs which prospectively utilize both diagnostic modalities to improve health monitoring for zebrafish colonies.


    Show Resources
    You May Also Like
    JAN 23, 2020 9:00 AM PST
    C.E. CREDITS
    JAN 23, 2020 9:00 AM PST
    DATE: January 23, 2020 TIME: 9:00am PST, 12:00pm EST...
    APR 07, 2020 8:00 AM PDT
    C.E. CREDITS
    APR 07, 2020 8:00 AM PDT
    DATE: April 7, 2020 TIME: 8:00am PT, 11:00am ET This webinar sets out to establish why quality control is key to robust, reliable, reproducible science. We will look at best practice criteri...
    FEB 26, 2020 9:00 AM PST
    C.E. CREDITS
    FEB 26, 2020 9:00 AM PST
    DATE: February 26, 2020 TIME: 9:00am PST 3D cell culture and analysis and the study of organoids and spheroids are becoming more prevalent as a research method in publications as traditional...
    MAY 08, 2020 10:00 AM PDT
    C.E. CREDITS
    MAY 08, 2020 10:00 AM PDT
    DATE: May 8, 2020 TIME: 10:00am PT, 11:00am MT, 1:00pm ET The application of next generation sequencing to interrogate immune repertoires and methods in which these highly complex dataset...
    JUN 09, 2020 10:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    C.E. CREDITS
    JUN 09, 2020 10:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    DATE: June 9, 2020 TIME: 10:00am PT, 1:00pm ET The presentation will first discuss sepsis as a disease and then explain the importance of performing diagnostic tests in the clinical labora...
    FEB 19, 2020 11:00 AM PST
    C.E. CREDITS
    FEB 19, 2020 11:00 AM PST
    DATE: February 19, 2020TIME: 11:00am PST, 2:00pm EST...
    Loading Comments...
    Show Resources